Mayo Clinic Minute: What is hepatitis C?
It's estimated that 2 to 3 million people in the U.S. are living with the hepatitis C virus, and hundreds of thousands of them are undiagnosed. That's primarily because it tends to be asymptomatic in the initial stages until liver damage sets in decades later. A recent study coauthored by Dr. Karthik Gnanapandithan, a hospitalist at Mayo Clinic, found that nearly 40% of people with hepatitis C living in the U.S. are not even aware… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 11, 2024 Category: Databases & Libraries Source Type: news
Scientists Discover Toxic Microplastics In Every Human Placenta Tested In Study
Authored by Naveen Athrappully via The Epoch Times (emphasis ours), Harmful microplastics have been found in human placenta, with some of them known to trigger asthma, damage the liver, cause cancer, and impair…#naveenathrappully #epochtimes #richardthompson #universityofplymouth #ben #matthewcampen #microplastic #placentas #microplastics (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
Millions of dementia patients my actually have 'very treatable' liver disease that has been misdiagnosed, according to 'unexpected' study
A new study of US veterans diagnosed with dementia found that many of them had liver disease, suggesting millions of people diagnosed with dementia could actually have a treatable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2024 Category: Consumer Health News Source Type: news
Semaglutide Cuts Liver Disease Severity in People With HIV
(MedPage Today) -- DENVER -- Semaglutide (Ozempic) reduced the amount of liver fat by nearly a third in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), the open-label phase IIb SLIM LIVER study showed.
In... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 9, 2024 Category: Gastroenterology Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Nivolumab Wins First-Line Indication in Metastatic UC Nivolumab Wins First-Line Indication in Metastatic UC
The FDA approved nivolumab alongside cisplatin and gemcitabine in the frontline for adults with unresectable or metastatic disease.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 8, 2024 Category: Urology & Nephrology Tags: Hematology-Oncology Source Type: news
Dartmouth woman says doctor shortage is hurting her search for a kidney donor
A Dartmouth woman facing tough odds to find a kidney donor says the lack of family doctors in Nova Scotia is complicating her search because they're needed to assess potential donors. (Source: CBC | Health)
Source: CBC | Health - March 8, 2024 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news
Study Links Tiny Bits of Plastic to Worse Heart Health
We breathe, eat, and drink tiny particles of plastic. But are these minuscule specks in the body harmless, dangerous, or somewhere in between?
A small study published Wednesday in the New England Journal of Medicine raises more questions than it answers about how these bits—microplastics and the smaller nanoplastics—might affect the heart. The Italian study has weaknesses, but is likely to draw attention to the debate over the problem of plastic pollution. Most plastic waste is never recycled and breaks down into these particles. “The study is intriguing. However, there are really substantial limitatio...
Source: TIME: Health - March 7, 2024 Category: Consumer Health News Authors: CARLA K. JOHNSON/AP Tags: Uncategorized healthscienceclimate Source Type: news
Ozempic Eases Fatty Liver Disease in People Living With HIV
THURSDAY, March 7, 2024 -- There ' s more good news around the diabetes and weight-loss drug Ozempic: It might help ease fatty liver disease in people living with HIV, new research shows.Six months of weekly injections of Ozempic (semaglutide)... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 7, 2024 Category: General Medicine Source Type: news
Ontario nuclear plant to produce material for life-saving cancer treatment
Ontario will announce plans Thursday to produce a nuclear medical isotope that forms the essential component in a life-saving treatment for liver cancer, one of the leading causes of cancer deaths. (Source: CBC | Health)
Source: CBC | Health - March 7, 2024 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
Oral SGLT2 Inhibitors Reverse MASLD in Diabetes Oral SGLT2 Inhibitors Reverse MASLD in Diabetes
Among oral antidiabetic drugs, SGLT2 inhibitors were linked to better liver outcomes in patients with both diabetes and MASLD in a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 7, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Metabolism May Explain Sex-Specific Kidney Disease Outcomes Metabolism May Explain Sex-Specific Kidney Disease Outcomes
Increased Krebs cycle metabolism in men vs pyruvate accumulation in women may underlie sex differences in diabetic kidney disease outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 6, 2024 Category: Consumer Health News Tags: Nephrology Source Type: news
CEUS shines in diagnostic, interventional settings
Dynamic contrast-enhanced ultrasound (CEUS) is a useful tool for interventions, according to a March 3 presentation given at ECR 2024. In his talk, Dean Huang, MD, from King’s College London in England outlined novel applications for CEUS in vascular and nonvascular imaging, as well as therapeutic and potential future applications. “Ultrasound contrast agent use can be ubiquitous in interventional practice and can solve many logistical or clinical diagnostic problems,” he said. “And we can achieve all of this without the use of radiation and nephrotoxicity.” Dean Huang, MD, from King's College London highligh...
Source: AuntMinnie.com Headlines - March 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Memorial's Kidney Transplant Program Nationally Ranked by the Scientific Registry for Transplant Recipients
Memorial Transplant Institute maintained its national ranking at number six for life-saving kidney transplants among 256 programs by The Scientific Registry for Transplant Recipients (SRTR). Memorial's Kidney Transplant Program earned the number one spot in the Miami Metro area and ranked... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 6, 2024 Category: Pharmaceuticals Source Type: news
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Tuesday, Novo Nordisk A/S NVO released the headline results from the kidney outcomes trial, FLOW. The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in kidney disease progression as well as cardiovascular and kidney death of 24% for people…#novonordiskasnvo #davitaincdva #novonordisk #novonordisks #ozempic #fresenius #davita #glp1 #ozempicandwegovy #citi (Source: Reuters: Health)
Source: Reuters: Health - March 5, 2024 Category: Consumer Health News Source Type: news
